D. A. Chappell

发表

High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

D. A. Chappell, 1989, The Journal of clinical investigation.

The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP.

J. Lalouel, D. Strickland, Sharon E. Williams, 1994, The Journal of biological chemistry.

Macrophage-Specific Expression of Human Lipoprotein Lipase Accelerates Atherosclerosis in Transgenic Apolipoprotein E Knockout Mice but Not in C57BL/6 Mice

C. Sigmund, K. Wilson, D. A. Chappell, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Ligand size as a determinant for catabolism by the low density lipoprotein (LDL) receptor pathway. A lattice model for LDL binding.

M. Waknitz, J. Berns, D. A. Chappell, 1991, The Journal of biological chemistry.

The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase.

M. Waknitz, D. Strickland, Sharon E. Williams, 1992, The Journal of biological chemistry.

Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

H. Wong, D. A. Chappell, G. Fry, 2000, Journal of lipid research.

The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor.

D. Strickland, J. Strauss, W. Argraves, 1994, The Journal of biological chemistry.

The 39-kDa Receptor-associated Protein Modulates Lipoprotein Catabolism by Binding to LDL Receptors (*)

D. Strickland, D. A. Chappell, G. Fry, 1995, The Journal of Biological Chemistry.

Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice.

D. Heistad, F. Faraci, K. Lamping, 1997, Arteriosclerosis, thrombosis, and vascular biology.

gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.

J. Henkin, R. Mallampalli, D. Strickland, 1995, Journal of cell science.

Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells.

L. Oberley, A. A. Spector, X. Fang, 1998, Circulation research.

Calcium-activated potassium channels mask vascular dysfunction associated with oxidized LDL exposure in rabbit aorta.

D. Gutterman, D. A. Chappell, F. Miller, 2001, Japanese heart journal.

Hepatic triglyceride lipase promotes low density lipoprotein receptor-mediated catabolism of very low density lipoproteins in vitro.

J. Hill, H. Wong, D. A. Chappell, 1999, Journal of lipid research.

Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene.

S. Tonstad, O. Rødningen, L. Ose, 1999, Journal of lipid research.

Pre-j #-Very Low Density Lipoproteins as Precursors of / l-Very Low Density Lipoproteins A Model for the Pathogenesis of Familial Dysbetalipoproteinemia ( Type Ill Hyperlipoproteinemia )

D. A. Chappell, 2003 .

Lipoprotein Lipase Binds to Low Density Lipoprotein Receptors and Induces Receptor-mediated Catabolism of Very Low Density Lipoproteins in Vitro*

J. Lalouel, D. Strickland, D. A. Chappell, 1996, The Journal of Biological Chemistry.

Glycoprotein 330/Low Density Lipoprotein Receptor-related Protein-2 Mediates Endocytosis of Low Density Lipoproteins via Interaction with Apolipoprotein B100 (*)

D. Strickland, S. Stefansson, W. Argraves, 1995, The Journal of Biological Chemistry.

Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro.

M. Waknitz, D. A. Chappell, G. Fry, 1993, The Journal of biological chemistry.

Evidence for isomerization during binding of apolipoprotein-B100 to low density lipoprotein receptors.

M. Waknitz, J. Berns, D. A. Chappell, 1992, The Journal of biological chemistry.

Regulation of low density lipoprotein receptors by adrenocorticotropin in the adrenal gland of mice and rats in vivo.

M. Brown, P. Kovanen, J. Goldstein, 1980, The Journal of biological chemistry.

Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice.

F. Faraci, K. Lamping, D. A. Chappell, 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

Receptor-mediated mechanisms of lipoprotein remnant catabolism.

D. A. Chappell, J. Medh, 1998, Progress in lipid research.

Role of the Ldl Receptor-Related Protein in Proteinase and Lipoprotein Catabolism

J. Lalouel, D. Strickland, W. Argraves, 1995 .

The Carboxy‐Terminal Domain of Lipoprotein Lipase Induces Cellular Catabolism of Normal Very Low Density Lipoproteins via the Low Density Lipoprotein Receptor—Related Protein/α2‐Macroglobulin Receptor

J. Lalouel, D. Strickland, D. A. Chappell, 1994, Annals of the New York Academy of Sciences.

The Cellular Internalization and Degradation of Hepatic Lipase Is Mediated by Low Density Lipoprotein Receptor-related Protein and Requires Cell Surface Proteoglycans (*)

D. Strickland, H. Wong, W. Argraves, 1995, The Journal of Biological Chemistry.

Lipoprotein and Lipid Metabolism: Basic and Clinical Aspects

A. A. Spector, D. A. Chappell, A. Spector, 1991 .

The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes (*)

D. Strickland, C. Maccalman, K. McCrae, 1995, The Journal of Biological Chemistry.

Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice.

F. Faraci, K. Lamping, D. A. Chappell, 1999, The American journal of physiology.

Glycoprotein 330, a member of the low density lipoprotein receptor family, binds lipoprotein lipase in vitro.

D. Strickland, W. Argraves, M. Kounnas, 1993, The Journal of biological chemistry.

Very low density lipoproteins stimulate surfactant lipid synthesis in vitro.

R. Mallampalli, R. G. Salome, D. A. Chappell, 1997, The Journal of clinical investigation.

Regulation of LDL receptor expression by luminal sterol flux in CaCo-2 cells.

F. Field, E. Born, S. Mathur, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Familial hypobetalipoproteinemia associated with a mutant species of apolipoprotein B (B-46).

S. Young, J. Terdiman, S. M. Snyder, 1989, The New England journal of medicine.

Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase.

J. Lalouel, D. Strickland, D. A. Chappell, 1994, The Journal of biological chemistry.

Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.

J L Witztum, R. Mahley, K. Weisgraber, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans.

M. Waknitz, D. Strickland, D. A. Chappell, 1993, The Journal of biological chemistry.

Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia).

D. A. Chappell, 1988, The Journal of clinical investigation.